UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
FORM 4
[ ] Check this box if no longer OMB APROVAL
subject to Section 16. Form 4 or OMB NUMBER: 3235-0287
Form 5 obligations may continue. Expires: September 30, 1998
See Instruction 1(b). Estimated average burden
hours per response........0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
1. Name and Address of Reporting Person*
Morgan Stanley Venture Capital III, Inc. (1)
- -----------------------------------------------------------------------------
(Last) (First) (Middle)
1221 Avenue of the Americas
- -----------------------------------------------------------------------------
(Street)
New York NY 10020
- -----------------------------------------------------------------------------
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Allscripts, Inc. (MDRX)
- -----------------------------------------------------------------------------
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
- -----------------------------------------------------------------------------
4. Statement for Month/Year
- -----------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Day/Year)
- -----------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
Director X 10% Owner
--- ---
Officer (give title below) Other (specify below)
--- ---
- ----------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
- ----
X Form filed by More than One Reporting Person
- ----
Table I -- Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned
<TABLE>
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired 5. Amount of Securities 6. Ownership 7. Nature of
(Instr. 3) action action (A) or Disposed of Beneficially Owned Form: Direct Indirect
Date Code (D) (Instr. 3, 4 at End of Month (D) or In- Beneficial
(Instr.8) and 5) (Instr. 3 and 4) direct (I) Ownership
(Month/ (Instr. 4) (Instr. 4)
Day/ (A) or
Year) Code V Amount (D) Price
- ------------------------- --------- ---- --- ------- --- --------- -------------------- -------------- -------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Series H Redeemable Through
Preferred Stock 7/28/99 J(2) 217,459 D $6.46(3) 0 I(4) Partnership(5)
Series I Redeemable Through
Preferred Stock 7/28/99 J(2) 1,199,770 D $6.46(3) 0 I(4) Partnership(5)
Series J Redeemable Through
Preferred Stock 7/28/99 J(2) 268,204 D $6.46(3) 0 I(4) Partnership(5)
Common Stock 7/28/99 C 787,895 A $7.50 5,926,552 I(4) Through
Partnership(5)
Common Stock 7/28/99 C 71,007 A $5.49 5,926,552 I(4) Through
Partnership(5)
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
(Over)
SEC 1474 (7-96)
<PAGE>
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
1. Title of 2. Conversion or 3. Transaction Date 4. Transaction 5. Number of 6. Date Exercisable and
Derivative Exercise Price (Month/Day/Year) Code Derivative Expiration Date
Security of Derivative (Instr. 8) Securities (Month/Day/Year)
(Instr. 3) Security Acquired (A)
or Disposed of
(D) (Instr. 3,
4 and 5)
Date Expiration
Code V (A) (D) Exercisable Date
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
Series A Convertible Preferred $7.50 7/28/99 C 234,242 Immed. (6)
Series B Convertible Preferred $7.50 7/28/99 C 118,979 Immed. (6)
Series C Convertible Preferred $7.50 7/28/99 C 385,265 Immed. (6)
Series D Convertible Preferred $7.50 7/28/99 C 680,675 Immed. (6)
Series F Convertible Preferred $7.50 7/28/99 C 693,887 Immed. (6)
Series G Convertible Preferred $5.49 7/28/99 C 173,089 Immed. (6)
1. Title of 7. Title and Amount of 8. Price of 9. Number of 10. Ownership 11. Nature of
Derivative Underlying Securities Derivative derivative Form of Indirect
Security (Instr. 3 and 4) Security Securities Derivative Beneficial
(Instr. 3) (Instr. 5) Beneficially Security: Ownership
Amount Owned at End Direct (D) (Instr. 4)
or of Month or Indirect
Number (Instr. 4) (I)
of (Instr. 4)
Title Shares
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
Series A Convertible Preferred Common Stock 39,977 -0- I(4) Through
Partnership(5)
Series B Convertible Preferred Common Stock 59,489 -0- I(4) Through
Partnership(5)
Series C Convertible Preferred Common Stock 164,379 -0- I(4) Through
Partnership(5)
Series D Convertible Preferred Common Stock 408,403 -0- I(4) Through
Partnership(5)
Series F Convertible Preferred Common Stock 115,647 -0- I(4) Through
Partnership(5)
Series G Convertible Preferred Common Stock 71,007 -0- I(4) Through
Partnership(5)
</TABLE>
Explanation of Responses:
(1) Please see attached Joint Filer Information.
(2) Securities were redeemable upon the initial public offering of the Issuer.
(3) Excludes payments of preferred dividends in arrears.
(4) Except for Morgan Stanley Venture Partners III, L.P., Morgan Stanley
Venture Investors III L.P. and The Morgan Stanley Venture Partners
Entrepreneur Fund, L.P. (collectively, the "Funds"), which hold the
securities directly.
(5) Pursuant to Instruction 4(b)(iv), the entire amount of Morgan Stanley
Venture Capital III, Inc.'s ("MSVC's) securities are being reported. The
reporting person disclaims beneficial ownership of the securities except
to the extent of its pecuniary interests as the institutional managing
member of Morgan Stanley Venture Partners III, L.L.C., the General Partner
of the Funds.
(6) Mandatory conversion upon the initial public offering of the Issuer.
/s/ Stephanie Holmes August 9, 1999
- ------------------------------- ------------------------
**Signature of Reporting Person Date
By: Stephanie Holmes, authorized
signatory for Morgan Stanley Dean
Witter & Co. and Assistant Secretary of
Morgan Stanley Venture Capital III, Inc.
institutional managing member of the
Funds.
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
Page 2
SEC 1474 (7-96)
<PAGE>
Joint Filer Information
Each of the following joint filers has designated Morgan Stanley Venture
Capital III, Inc. ("MSVC III, Inc.") as the "Designated Filer" for purposes
of the attached Form 4:
(1) Morgan Stanley Dean Witter & Co. ("MSDW")
1585 Broadway
New York, New York 10036
(2) Morgan Stanley Venture Partners III, L.L.C., ("MSVP III,
L.L.C.") 1221 Avenue of the Americas New York, New York
10020
(3) Morgan Stanley Venture Partners III, L.P. ("MSVP III, L.P.")
1221 Avenue of the Americas
New York, New York 10020
(4) The Morgan Stanley Venture Partners Entrepreneur Fund, L.P.
("Entrepreneur Fund")
1221 Avenue of the Americas
New York, New York 10020
(5) Morgan Stanley Venture Investors III, L.P. ("MSVI")
1221 Avenue of the Americas
New York, New York 10020
Issuer & Ticker Symbol: Allscripts, Inc. (MDRX)
Date of Event Requiring Statement: 7/28/99
Signature: /s/ Stephanie Holmes
--------------------------------------------
By: Stephanie Holmes, as authorized signatory for
MSDW and Assistant Secretary of MSVC III, Inc.,
institutional managing member of MSVP III, L.L.C.,
the General Partner of MSVP III, L.P., the Entrepreneur
Fund, and MSVI
Page 3 of 3
